Most Read Articles
02 Dec 2017
The risk of congenital heart disease (CHD) Is significantly higher in foetuses conceived through in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI), according to a recent study.
Pearl Toh, 4 days ago
A higher dose of pitavastatin can benefit Japanese patients with stable coronary artery disease (CAD) compared with a low-dose pitavastatin, even though cardiovascular (CV) event incidence is known to be lower in Asian than Western patients, according to the REAL-CAD study presented at the AHA Scientific Sessions 2017.
01 Apr 2014
The basic life support (BLS) termination of resuscitation (TOR) rule recommends transport and continued resuscitation when cardiac arrest is witnessed by EMT-Ds, or there is a return of spontaneous circulation, or a shock is given.
03 Dec 2017
Treatment with the triple combination of amlodipine, losartan and rosuvastatin appears to be an effective therapeutic strategy for lowering blood pressure and low-density lipoprotein (LDL)-C levels in patients with comorbid hypertension and dyslipidaemia, according to a study.

Weight gain, dyslipidaemia, hypertension common after adjuvant chemo for breast cancer

02 Sep 2017

Hypertension, dyslipidaemia and an abnormal 60-percent increase in body mass index (BMI) are common complications in premenopausal breast cancer patients who have received adjuvant chemotherapy, a recent study in a Chinese population has found.

The study included 280 breast cancer patients (median age 46.5 years), of which 88 had stage I, 165 had stage II and 27 had stage III. Oestrogen receptor (ER)-positive cancers were observed in 73 percent, progesterone receptor (PR)-positive in 67 percent and HER2-positive in 17 percent.

At study entry, 63.2 percent (n=177) experienced >2 percent weight gain since breast cancer diagnosis. Of these, 121 had a weight gain of 5 percent.

Multivariate analysis showed that taxane-containing chemotherapies (odds ratio [OR], 2.041; 95 percent CI, 1.127 to 3.696; p=0.0186) and chemotherapy-related amenorrhoea (CRA; OR, 3.472; 1.395 to 8.621; p=0.0074) were independent factors for weight gain >2 percent.

Of the participants, 30.7 percent (n=86) were hypertensive, 13.2 percent (n=37) had elevated systolic blood pressure (SBP) and 3.9 percent (n=11) had elevated diastolic blood pressure (DBP). SBP and DBP were elevated in 13.6 percent (n=38).

Overweight or obesity at study entry (OR, 2.723; 1.568 to 4.728; p=0.0004) and ER-positivity (OR, 0.552; 0.311 to 0.980; p=0.0423) were significantly related to hypertension.

In terms of fasting serum lipid levels, 34.3 percent (n=93) had high total cholesterol, 56.1 percent (n=152) had high low-density lipoprotein cholesterol (LDL-C), 6.6 percent (n=18) had high high-density lipoprotein cholesterol (HDL-C) and 22.9 percent (n=62) had hypertriglyceridemia.

Overweight or obesity at study entry was a consistent significant factor for high total cholesterol (OR, 1.764; 1.013 to 3.073; p=0.0451), high LDL-C (OR, 2.560; 1.410 to 4.649; p=0.0020), high HDL-C (OR, 7.786; 1.742 to 34.795; p=0.0072) and high triglyceride (OR, 2.775; 1.446 to 5.325; p=0.0021).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
02 Dec 2017
The risk of congenital heart disease (CHD) Is significantly higher in foetuses conceived through in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI), according to a recent study.
Pearl Toh, 4 days ago
A higher dose of pitavastatin can benefit Japanese patients with stable coronary artery disease (CAD) compared with a low-dose pitavastatin, even though cardiovascular (CV) event incidence is known to be lower in Asian than Western patients, according to the REAL-CAD study presented at the AHA Scientific Sessions 2017.
01 Apr 2014
The basic life support (BLS) termination of resuscitation (TOR) rule recommends transport and continued resuscitation when cardiac arrest is witnessed by EMT-Ds, or there is a return of spontaneous circulation, or a shock is given.
03 Dec 2017
Treatment with the triple combination of amlodipine, losartan and rosuvastatin appears to be an effective therapeutic strategy for lowering blood pressure and low-density lipoprotein (LDL)-C levels in patients with comorbid hypertension and dyslipidaemia, according to a study.